Listed

Biofrontera Inc.

BFRINasdaqCIK 1858685HealthcareFiscal year ends Dec 31

Reports and events: 166 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Biofrontera Inc., Reports and events
FiledFormWhat it isAccession number
2024-11-2209:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-047306
2024-11-1418:00 ET10-QQuarterly reportPeriod 2024-09-300001493152-24-045220
2024-11-1317:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-045205
2024-10-3115:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-043187
2024-10-0708:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-039652
2024-08-1416:49 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-032328
2024-08-1416:15 ET10-QQuarterly reportPeriod 2024-06-300001493152-24-032216
2024-06-2408:34 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-024881
2024-06-1416:30 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-24-023888
2024-05-2216:30 ET8-K8.01 Other events0001493152-24-021019
2024-05-1517:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-020031
2024-05-1516:16 ET10-QQuarterly reportPeriod 2024-03-310001493152-24-019878
2024-05-0309:15 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-017641
2024-05-0321:32 ETS-1Registration statement0001493152-24-017613
2024-04-3016:40 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-24-017255
2024-04-2516:45 ET8-K5.07 Shareholder vote results0001493152-24-015949
2024-04-1717:21 ETDEF 14AProxy statementPeriod 2024-04-170001493152-24-015042
2024-04-0317:00 ET8-K/A8.01 Other events0001493152-24-013031
2024-03-2616:45 ET8-K5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-011323
2024-03-2120:41 ETDEF 14AProxy statementPeriod 2024-03-200001493152-24-010706
2024-03-2020:44 ETS-1/ARegistration statement, amended0001493152-24-010552
2024-03-1517:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-010152
2024-03-1517:00 ET10-KAnnual reportPeriod 2023-12-310001493152-24-010133
2024-03-1118:45 ETS-1Registration statement0001493152-24-009456
2024-02-2309:26 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-007616
2024-02-2009:37 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-007143
2024-02-1321:39 ET8-K8.01 Other events0001493152-24-005946
2024-02-0517:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-004964
2024-02-0216:30 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-004771
2024-01-2909:23 ETS-1/ARegistration statement, amended0001493152-24-004089
2024-01-2516:30 ET8-K3.01 Delisting notice0001493152-24-003756
2024-01-1719:23 ETS-1Registration statement0001493152-24-002533
2024-01-1116:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-002083
2024-01-0917:01 ET8-K/A1.02 Termination of a material agreement0001493152-24-001848
2024-01-0317:27 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-000334
2023-12-2817:25 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation0001493152-23-046414
2023-12-2717:00 ET8-K5.07 Shareholder vote results0001493152-23-046279
2023-12-1517:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-045074
2023-11-2916:30 ET8-K3.01 Delisting notice0001493152-23-043068
2023-11-1706:02 ETDEF 14AProxy statementPeriod 2023-11-170001493152-23-041752
2023-11-0917:23 ET10-QQuarterly reportPeriod 2023-09-300001493152-23-040132
2023-11-0917:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-040113
2023-11-0217:10 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-039171
2023-10-2721:00 ETS-1/ARegistration statement, amended0001493152-23-038442
2023-10-1621:59 ETS-1/ARegistration statement, amended0001493152-23-037266
2023-10-1317:26 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-037236
2023-10-1009:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-036673
2023-10-0521:48 ETS-1Registration statement0001493152-23-035722
2023-10-0408:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-035321
2023-10-0317:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-035275

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 22:16 ET. Listed shows no prices and gives no investment advice.